Low Back Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The treatment group (1) patients with untreated low back pain; (2) the waist has good function and can withstand the movements required by the test; (3) not taking nsaids within 10 days; (4) no allergy to celecoxib or any other component of the drug; (5) agree to participate in the experiment. The control group (1) no lumbar deformity; (2) no history of lumbar spine injury or chronic spinal muscle disease (3) no chronic lumbar pain; (4) CT examination was followed by 1 imaging specialist and 1 spinal surgery specialist identified no lumbar spine injury or paraspinal muscle disease was exsit.
Exclusion criteria
Exclusion criteria: The treatment group (1) a history of back surgery; (2) spinal malignancy, infection, fracture, cauda equina syndrome or ankylosis; spondylitis or other inflammatory diseases; spinal deformity, such as lumbar spondylolisthesis; (3) other systemic diseases, such as diabetes and kidney disease; (4) patients who had received psoas muscle training in the past year. (5) unable to complete all the research steps; (6) patients with active gastrointestinal ulcer/bleeding; (7) people with severe osteoporosis, high blood pressure and heart disease. The control group (1) other systemic diseases such as diabetes, myasthenia gravis, etc (2) recent fever, or intestinal or bladder dysfunction (3) unable to complete all the research steps; (4) plan to become pregnant or suspect because of possible harm to the fetus caused by X-ray Fertile women who may become pregnant are excluded from the trial; (5) contraindication of mri; (6) do not accept radiation inspection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total spinal parameter; | — |
Countries
China
Contacts
Department of Spinal Surgery, Shanghai Tongji Hospital